Adult

Gentamicin

Warning

General Information

Aminoglycoside

Formulary antimicrobial: Use in accordance with Trust guidelines

AWaRe antibiotic classification: 'Access'. Use as per guidelines.

Note: There is an EPR powerplan associated with this drug.

  • Gentamicin is given intravenously. Where this route is unavailable, it can be given by intramuscular injection.  
  • This monograph does not cover intra-aural administration. 
  • For Infective Endocarditis Treatment see Gentamicin - infective endocarditis monitoring
  • Review need for gentamicin daily. Gentamicin should not be administered for more than three days without discussion with Micro/ID.

For all information regarding contra-indications, interactions, contraception, pregnancy and breastfeeding and additional information, see BNF and Summary of Product Characteristics (SPC).

Monitoring

  • Baseline renal function should be measured, and creatinine clearance calculated.
  • Monitor renal function daily.  If there is a greater than 15% change in serum creatinine re-calculate creatinine clearance and adjust dose. 
  • Take a baseline weight and then monitor weekly. Adjust dose if weight changes. 
  • Take daily U+Es.
  • Monitor serum gentamicin levels (see below). 
  • Auditory function may be affected. Please refer to Audiometry and intravenous aminoglycosides. 

Gentamicin IV - Calculating initial dose

Where possible, creatinine clearance should be calculated before deciding the dosing of gentamicin. 

The EPR gentamicin calculator will launch automatically when gentamicin is prescribed. This calculator will calculate the dosing weight. In order to do this, an accurate weight and height will need to be entered on EPR. This calculator will calculate a dose and rounds down to the nearest 20mg. This calculator is capped with a maximum dose of 480mg.

gentamicin 5mg/kg: dose should be capped at maximum dose of 480mg. 

gentamicin 3mg/kg (for both surgical prophylaxis and patients with reduced creatinine clearance): dose should be capped at a maximum dose of 240mg

For Adult Critical Care areas that use CareVue, or in the case of EPR downtime, use the following guideline (On OUH Intranet): EPR Downtime Guide 

STEP 1. Determine Creatinine Clearance (CrCl)

Use Estimated Creatinine Clearance calculator on EPR. Note that there are two calculators (male and female) so chose appropriate calculator.

OR

Determine Creatinine Clearance (CrCl) using the Cockcroft-Gault equation (below).

CrCl (mL/min) = F x (140-age) x weight (kg)   

                             Serum Cr (micromol/L)

where F=1.04 (females) or F=1.23 (males)

  • Use Ideal Body Weight (IBW) if Actual Body Weight (ABW) is over 20% above IBW.
  • In patients with low serum creatinine (less than 60 micromol/L), use 60 micromol/L to calculate creatinine clearance). 

 

STEP 2. Calculate initial gentamicin dose

Usual treatment dose (CrCl 31 ml/min and over)

5mg/kg IV (maximum dose of 480mg)

Renal impairment treatment dose (CrCl 30ml/min or less) 

If patient is on dialysis, consult with renal team before administering gentamicin. 

 

3 mg/kg IV (maximum dose of 240mg)

 

Treatment of bacterial endocarditis

Consult Micro/ID.

See also Infective Endocarditis Treatment

Surgical prophylaxis (See General Principles)

3mg/kg IV single dose (maximum dose of 240mg)

 

STEP 3. Prescribe on EPR. The Gentamicin Calculator will launch automatically. 

Prescribers are required to ensure: 

  1. Dosing weight and height is accurate or best estimate. 
  2. Dose provided by calculator is in the expected range. 

Ensure that "Apply dose" is clicked to prescribe the dose on drug chart. For further information on how to use the calculator see: Gentamicin calculator - how to guide (v1.1).pdf 

NOTE: If actual body weight is less than ideal body weight, the EPR calculator will not calculate the dose. Prescribers need to:

1) Manually enter the patient's actual body weight into the box for 'Adjusted weight'. 

2) Change 'Adjustment' box to Actual (no adjustment) as shown in the example image below:

The calculator will now calculate the correct dose. 

Gentamicin level and dose adjustment for 5mg/kg dose

STEP 4. Responding to gentamicin levels if creatinine clearance 31ml/min or greater 

  • Take serum gentamicin level (yellow blood tube) 6-14 hours after administration of first dose of gentamicin. 
  • Once level available, plot on nomogram below and adjust time interval as required. 
  • If gentamicin level is not available at 24 hours post first dose: check table below for when to give the next dose (time interval)*. 

 

  • For gentamicin 3 day courses: After calculating dosing interval from nomogram below:
        • If interval is 24 hours - give 2 further doses at the appropriate time.
        • If interval is 36 or 48 hours -  give 1 further dose at the appropriate time.
  • For prolonged courses if renal function is stable, repeat gentamicin levels should be taken twice a week.
  • Take daily U+E. If renal function is deteriorating review use of gentamicin as this is a nephrotoxic medicine.

     

Gentamicin 5mg/kg nomogram

 

* If gentamicin level is not available at 24 hours, suggested time intervals for 5mg/kg dose are:

Calculated Creatinine Clearance 

Time interval

Where the gentamicin course is for 3 days

60 ml/min or greater 

24 hours

Give 2 further doses at the appropriate time.

40 to 50 ml/min

36 hours

Give 1 further dose at the appropriate time

30 to 39 ml/min

48 hours

Give 1 further dose at the appropriate time

Less than 30 ml/min

Take a gentamicin level at 24 hours after dose and do not re-dose until serum level (TDM) is less than 1mg/L. 

Gentamicin level and dose adjustment for 3mg/kg dose

STEP 4. Responding to gentamicin levels if creatinine clearance 30ml/min or less

  • Take gentamicin level 24 hours after dosing. Continue taking levels every 12 hours until level is less than 1mg/L. Only re-dose once level is less than 1mg/L.
  • For patients on a 3 day course the patient may only be given 1 dose if level remains above 1mg/L.
  • Take daily U+E. 

References

Nomogram was adapted from the Lancashire NHS Foundation Trust gentamicin guideline

Editorial Information

Last reviewed: 03 Nov 2026

Next review date: 01 Nov 2029

Author(s): AMST.